Ardelyx (ARDX)
(Delayed Data from NSDQ)
$5.13 USD
+0.74 (16.86%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $5.12 -0.01 (-0.19%) 4:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ARDX 5.13 +0.74(16.86%)
Will ARDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARDX
Ardelyx (ARDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
ARDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics
Other News for ARDX
Ardelyx (ARDX) Shares Cross Above 200 DMA
Wedbush Raises Ardelyx (ARDX) Price Target, Maintains Outperform Rating | ARDX Stock News
ARDX: Raymond James Raises Price Target to $12.00, Maintains Outperform Rating | ARDX Stock News
Wedbush Increases Ardelyx (ARDX) Price Target Following Strong Q2 Performance
Ardelyx (ARDX) Price Target Raised by Wedbush Following Strong Q2 Performance